Mitchell Creem serves as Executive at Clinigence Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Mitchell Creem has executed 5 insider transactions totaling $634.9M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 14, 2023 involved purchasing 50,000 shares valued at $21.5K.
Mitchell Creem currently holds 81,746 shares of Clinigence Holdings, Inc. (CLNH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mitchell Creem has been a net buyer of CLNH stock. They have purchased $634.9M and sold $0 worth of shares.
Mitchell Creem's most recent insider trade was on Jun 14, 2023, when they purchased 50,000 shares at $0.43 per share.
Get notified when new Form 4 filings are submitted
| $3.89 |
| Discretionary |
| May 9, 2022 | NUTX | $0 | Other | 21,208 | $N/A | Discretionary |
| May 9, 2022 | NUTX | $82.5K | Award | 21,208 | $3.89 | Discretionary |
| Aug 12, 2020 | CLNH | $634.9M | Purchase | 31,746 | $20000.00 | Discretionary |